TORONTO -- The inexpensive and well-known drug fluvoxamine can save the lives of COVID-19 patients and cut hospital admissions by up to 30 per cent, according to a new study.
, treated 741 randomly selected Brazilian COVID-19 patients with fluvoxamine, and another 756 with a placebo. All of the patients were treated from Jan. 15 to Aug. 6 of 2021, and were monitored for 28 days. All of the patients were unvaccinated.
Dr. Edward Mills, the co-principal investigator of the trial, said the results could be a potential game-changer, particularly in developing countries with low vaccination rates. Fluvoxamine has been used since the 1990s and its safety profile is well known, says Mills. It costs about $4 per 10-day course, which is far cheaper than other treatments, he said.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Report: At least 59,000 U.S. meat workers caught COVID-19, 269 diedAt least 59,000 meatpacking workers caught COVID-19 and 269 workers died when the virus tore through the industry last year, which is significantly more than previously thought, according to a new U.S. House report released Wednesday.
Read more »
B.C. adds 609 cases of COVID-19, 6 deaths as hospitalizations climb againThe B.C. government has announced 609 new cases of COVID-19 and six related deaths, along with another increase in coronavirus hospitalizations.
Read more »
Immunocompromised may need a fourth COVID-19 shot, CDC saysPeople with certain health conditions that make them moderately or severely immunocompromised may get a fourth mRNA COVID-19 shot, according to updated guidelines from the U.S. Centers for Disease Control and Prevention.
Read more »
COVID-19: Survey suggests Canadian workers are worried about career growth if working remotelyOut of sight, out of mind? A new survey suggests some workers are worried remote or hybrid work could limit their career growth.
Read more »
At least 59,000 U.S. meatpacking workers got COVID-19 in first year, report saysThe report cited examples of individual plants where infection rates soared as high as 54 per cent of the workforce
Read more »